TB Alternative Assets’s Cameco CCJ Stock Holding History

TB Alternative Assets’s Portfolio CCJ Stock Details CCJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-167,800	Closed	-$3.53M	–	43
2022 Q2	$3.53M	Sell	167,800 -99,600	-37%	-$2.51M	1.73%	16
2022 Q1	$7.78M	Buy	+267,400	New	+$6.27M	2.67%	11
2017 Q2	–	Sell	-397,200	Closed	-$4.4M	–	23
2017 Q1	$4.4M	Buy	+397,200	New	+$4.53M	3.16%	8

Other funds holding CCJ

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

TB Alternative Assets's CCJ Position: Q3 2022 in Review

TB Alternative Assets sold out of Cameco (CCJ) in Q3 2022, closing a stake of 167,800 shares — an estimated $3.53M sold.

TB Alternative Assets first reported a position in CCJ in Q1 2017 and held it in 3 quarters. The position peaked at $7.78M in Q1 2022. 469 funds tracked by Wall St. Rank hold CCJ as of Q3 2022.

TB Alternative Assets reported no remaining Cameco position as of Q3 2022 after selling out during the quarter.
TB Alternative Assets sold 167,800 Cameco shares in Q3 2022, an estimated $3.53M.
TB Alternative Assets first reported a position in Cameco in Q1 2017 and held it in 3 quarters.
TB Alternative Assets's Cameco position peaked at $7.78M in Q1 2022.
469 funds tracked by Wall St. Rank held Cameco as of Q3 2022.

Based on TB Alternative Assets's 13F filing for Q3 2022, filed 14 Oct 2022.